June 2020
CIPA Journal
Another challenge to the propriety of the Patent Trial and Appeal Board (PTAB) – is the Federal Circuit’s Arthrex decision the beginning or the end of this new debate? Emily Gabranski and Tim McAnulty discuss the ramifications and how they are unravelling.
Read the full article here.
United States Patent and Trademark Office (USPTO), Arthrex v. Smith & Nephew , Patent Trial and Appeal Board (PTAB), United States Court of Appeals for the Federal Circuit (CAFC)
Originally printed in CIPA Journal on June 2020. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
10th Annual Georgia Asian Pacific American Bar Association Gala
May 29, 2024
Atlanta
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.